Congress expands newborn screening for serious viral infection
H.R. 5435 — Stop CMV Act of 2025 · Filed by Michael Lawler (R-NY) · 11 cosponsors · Introduced Sep 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires hospitals to offer newborn screening for congenital Cytomegalovirus (CMV), a viral infection that can cause hearing loss, developmental delays, and other serious complications in infants. It authorizes federal grants to states to develop screening standards, train healthcare providers, and fund research into better screening methods and treatments, with no mandatory screening—hospitals and states may choose to participate.
Why we flagged it
The bill establishes a voluntary newborn screening program for a serious congenital infection, funded through federal grants to states and research institutions. It is a straightforward public-health measure with no hidden mechanisms or narrow beneficiaries.
What the text implies
- The bill's reliance on state-level implementation and the 2-year timeline for state adoption may create uneven screening availability across states, potentially leaving infants in less-resourced states without access to early detection.
- The authorization of 'such sums as may be necessary' for fiscal years 2025–2026 provides no spending cap; actual appropriations will depend on future congressional action and may be insufficient to fund all states.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical companies developing CMV vaccines and antivirals; diagnostic test manufacturers; healthcare providers and hospitals administering screening